Merus N.V. and Halozyme Therapeutics Inc. have entered into a global non-exclusive collaboration and license agreement.

AdvanCell Pty Ltd, a clinical-stage radiopharmaceutical company, has appointed Philina Lee, PhD as CEO and member of the ...

Sonoma Biotherapeutics Inc. has appointed Stephen Dilly, former President and CEO of Codexis Inc., and current Chair of the ...

Ono Pharmaceutical Co. Ltd. has opened a new 733-square-meter office in Zug, Switzerland to accommodate the company’s growth ...

Tyruko (natalizumab) is the first and only biosimilar for Multiple Sclerosis. Polpharma Biologics, a biopharmaceutical company group focused on biosimilars development and manufacturing, confirmed ...

Q Earnings: $5.8 billion (+83%) YTD Revenues: $48.6 billion (flat) YTD Earnings: $15.3 (+14%) Comments: KEYTRUDA sales were ...

TandemAI has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced ...

Global biopharmaceutical sales were $16.3 billion, down 6%. Primary Care sales were down 16% to $7.6 billion. Eliquis sales ...

BostonGene and Kyoto University have entered a research collaboration to develop advanced biological signatures.

Merck has entered a definitive agreement to acquire Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate ...

3Q Earnings: $186 million (earnings were $1.6B 3Q24) YTD Revenues: $44.5 billion (+8%) YTD Earnings: $2.4 billion (-44%) ...

The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of ...